Zheng Xiaoman, Ding Wenshuang, Zhu Zhigang, Li Junping, Zhong Weijie
Department of Geriatrics, Hematology & Oncology Ward, Guangzhou First People's Hospital, Guangdong Medical University, Guangzhou, Guangdong, China.
Department of Pathology, Guangzhou First People's Hospital, Guangdong Medical University, Guangzhou, Guangdong, China.
Front Oncol. 2024 Dec 5;14:1472560. doi: 10.3389/fonc.2024.1472560. eCollection 2024.
Hodgkin lymphoma variant of Richter syndrome (HL-type RS) is a very rare disease, in which chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) is transformed into novel Hodgkin lymphoma. The most important prognostic factor of HL-type RS is the clonal relationship between HL-type RS and the preexisting CLL/SLL. Detailed confirmation of clonally unrelated HL-type RS cases have not been reported. To the best of our knowledge, this is the first case of HL-type RS confirmed as clone independent by a detailed comparison of immunoglobulin gene rearrangement clones and gene mutations. A 76-year-old man, diagnosed with SLL 1 year before transformation was treated with Zanubrutinib 3 months before transformation. When diagnosed with HL-type RS, he presented with symptoms of hemophagocytic syndrome. Positive therapeutic effects were achieved using a modified rituximab-doxorubicin, bleomycin, vinblastine, dacarbazine regimen in combination with Zanubrutinib. We also discuss a thorough review of the relevant literature we performed to help us better understand this rare disease.
里氏综合征的霍奇金淋巴瘤变体(HL型RS)是一种非常罕见的疾病,其中慢性淋巴细胞白血病(CLL)或小淋巴细胞淋巴瘤(SLL)会转化为新的霍奇金淋巴瘤。HL型RS最重要的预后因素是HL型RS与先前存在的CLL/SLL之间的克隆关系。尚未有关于克隆无关的HL型RS病例的详细证实报道。据我们所知,这是首例通过免疫球蛋白基因重排克隆和基因突变的详细比较确认为克隆独立的HL型RS病例。一名76岁男性,在转化前1年被诊断为SLL,在转化前3个月接受了泽布替尼治疗。当被诊断为HL型RS时,他出现了噬血细胞综合征的症状。使用改良的利妥昔单抗-阿霉素、博来霉素、长春花碱、达卡巴嗪方案联合泽布替尼取得了积极的治疗效果。我们还讨论了我们对相关文献进行的全面回顾,以帮助我们更好地了解这种罕见疾病。